SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995. It specializes in early-stage investments, focusing on deep technology innovations that address human and planetary health. The firm operates startup development programs, notably HAX and IndieBio, which provide resources, facilities, and lab equipment to accelerate the growth of promising startups. SOSV supports companies from their inception through various funding stages, including seed and series A rounds, while offering ongoing assistance to help them scale and attract additional investors. By concentrating on revolutionary technologies and cross-border markets, particularly in Asia, SOSV aims to foster significant advancements that benefit humanity and the environment.
Kotal is a developer of cloud-native deployment tools focused on managing the lifecycle of blockchain infrastructure. Founded in 2020 and based in Middletown, Delaware, the company offers a platform that facilitates the deployment of self-managing and self-healing blockchain systems for clients. Its platform includes a range of features such as open-source tools, protocol agnosticism, key management, and multi-client support. These features enable clients to effectively oversee all aspects of blockchain infrastructure, from deployment and integration to security, logging, and monitoring.
Pregenerate
Convertible Note in 2022
Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.
Aylien
Convertible Note in 2021
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Pregenerate
Seed Round in 2021
Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.
Pregenerate
Seed Round in 2020
Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.
Aylien
Series A in 2019
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Bioptamers
Seed Round in 2019
Bioptamers, Inc. is a biotechnology company focused on developing cellular and gene therapies for cancer treatment. Founded in 2018 and headquartered in New Castle, Delaware, with an additional office in São Paulo, Brazil, the company aims to create personalized therapeutic delivery technologies using monoclonal antibodies and antibody-drug conjugates. Bioptamers is working on optimizing aptamer selection to tailor cancer therapies to individual patient needs. This process involves creating DNA aptamers that specifically bind to cancer cells, facilitating personalized precision therapies. By transforming these molecules into clinically valuable products, Bioptamers seeks to license them to pharmaceutical companies and improve clinical outcomes for cancer patients in collaboration with private companies and hospitals.
Pregenerate
Pre Seed Round in 2019
Pregenerate, Inc. is a company focused on developing organ-on-a-chip technology to replace animal testing in medical and pharmaceutical research, specifically for arthritis treatments. Founded in 2019 and incorporated in Delaware, Pregenerate offers scalable models that utilize human cells, allowing pharmaceutical companies to enhance drug development efficiency and reduce costs significantly. This innovative approach not only improves the success rates of bringing drugs to market but also enables the stratification of patients into targeted treatment subgroups. Ultimately, Pregenerate's technology aims to provide personalized treatment recommendations for individuals based on their specific arthritis needs, thereby advancing the field of personalized medicine in healthcare.
Aylien
Venture Round in 2017
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Aylien
Venture Round in 2016
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Aylien
Seed Round in 2011
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Aylien
Seed Round in 2010
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.